Improving Psychological Wellness After Acquired Brain Injury
NCT ID: NCT00866632
Last Updated: 2010-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
75 participants
INTERVENTIONAL
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Cognitive Behavioural Therapy
Cognitive Behavioural Therapy
Cognitive behavioural therapy to be delivered in a group setting for 11 sessions, for 1 to 1.5 hours/session.
Telephone Cognitive Behavioural Therapy
Cognitive Behavioural Therapy
Cognitive behavioural therapy to be delivered in one-on-one via the telephone across 11 sessions, for 1 to 1.5 hours/session.
Group Education
No interventions assigned to this group
Telephone Education
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavioural Therapy
Cognitive behavioural therapy to be delivered in a group setting for 11 sessions, for 1 to 1.5 hours/session.
Cognitive Behavioural Therapy
Cognitive behavioural therapy to be delivered in one-on-one via the telephone across 11 sessions, for 1 to 1.5 hours/session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Moderate to severe brain injury, operationalized as a GCS of 12 or less in TBI participants and cognitive impairment of at least two standard deviations below expected levels in at least one cognitive domain in all participants
* on a stable dosage and being monitored by a physician(if on psychoactive medications)
* able to provide informed consent
Exclusion Criteria
* Engaged in another CBT or other psychotherapeutic intervention
* Communication disorder that would preclude participation in the intervention
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ontario Neurotrauma Foundation
OTHER
Peel Halton Acquired Brain Injury Services
UNKNOWN
Toronto Rehabilitation Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Toronto Rehabilitation Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robin E Green, Ph.D., C.Psych
Role: PRINCIPAL_INVESTIGATOR
Toronto Rehabilitation Institute
Cheryl Bradbury, Psy. D., C. Psych
Role: STUDY_CHAIR
Toronto Rehabilitation Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peel Halton Acquired Brain Injury Service
Mississauga, Ontario, Canada
Toronto Rehabilitation Institute
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-ABI-COP-538
Identifier Type: -
Identifier Source: org_study_id